Skip to content

Author

R. Takkenberg

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Porto-sinusoidal vascular disorder-type lesions in patients with early fibrotic stages of metabolic dysfunction-associated steatotic liver disease.

BACKGROUND AND OBJECTIVE Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising cause of chronic liver disease. Liver stiffness measurement (LSM) to assess disease stage is gaining popularity but can demonstrate heterogeneous results in clinical practice. Moreover, portal hypertension may develop...

Diederick J. van Doorn, L. Schoenmakers, S. de Jager et al. · 0 citations
Open access Sep 2026

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

THRI appears more effective than aMAP in identifying patients with negligible 5-year HCC risk and may inform personalized HCC surveillance strategies, particularly in supporting deferral decisions in low-risk patients.

Mohamed Moussa, K. de Wit, L. Baak et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.